Today, the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) have awarded the Herbert A. Fleisch ESCEO-IOF Medal to Dr Stefania Maggi, Research Director at the Consiglio Nazionale delle Ricerche (CNR) Aging Branch-Institute of Neuroscience in Padua and Director of the CNR Project on Ageing. The Award was presented at the opening of the virtual congress WCO-IOF-ESCEO 2020.
The Herbert A. Fleisch ESCEO-IOF Medal recognizes a researcher who has made outstanding and ground-breaking achievements in basic bone science or musculoskeletal research. It is named after the late Professor Herbert Fleisch, whose pioneering work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment.
Professor Jean-Yves Reginster, ESCEO President and Co-Chair of WCO-IOF-ESCEO 2020 noted:
“ESCEO and IOF are very honoured to present this prestigious Award to Dr Stefania Maggi, an eminent researcher who has made major contributions to the field of healthy ageing. As a highly respected investigator in clinical geriatrics and epidemiology, she has advanced the epidemiology of chronic conditions associated with the ageing process, has led pharmacological and non-pharmacological clinical trials in the field of ageing and chronic conditions, and is a leading scientific collaborator, both nationally and internationally, in health services research for the ageing population.”
Dr Maggi is a geriatrician and epidemiologist with expertise in both areas of Clinical Geriatrics and Epidemiology of Ageing. Her research focuses on the epidemiology of ageing and on the analysis of the impact that lifelong health promotion and disease prevention programs have on healthy ageing. She is a Board-Certified Geriatrician (University of Padua, Italy) and also obtained a Master in Public Health in Epidemiology in 1987 and completed a two-year Post-Doctoral Training in Epidemiology, both at the Johns Hopkins University, in Baltimore, MD, USA. Dr Maggi was the Coordinator of the Program for Research on Ageing of WHO, from 1990 to 1993, based at NIA, NIH, Bethesda, MD, USA.
In 2016-2017 she was the President of the European Geriatric Medicine Society (EuGMS), after four years as Director of the Academic Board. Dr Maggi is currently working as Research Director at the CNR Aging Branch-Institute of Neuroscience in Padua and is the Director of the CNR Project on Ageing, involving 22 multidisciplinary, research centers in Italy. She is a member of the IOF Committee of Scientific Advisors and of the Scientific Advisory Board of ESCEO, as well as member of several working groups of IOF, ESCEO, and EuGMS. She is currently the President of the Mediterranean Diet Foundation, a member of the Board of Directors of the American Federation for Aging (AFAR), New York, NY, US and of the Italian Society of Gerontology and Geriatrics (SIGG).
Dr Maggi has authored over 400 publications in international peer-reviewed journals and is currently the Editor in Chief of Aging Clinical and Experimental Research.
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. WCO-IOF-ESCEO 2020 is held as a virtual Congress ( http://virtual.wco-iof-esceo.org/). The 2021 WCO-IOF-ESCO is planned in London, UK from April 8-11, 2021. For complete information visit www.wco-iof-esceo.org #OsteoCongress
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. www.esceo.org
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 260 patient, medical and research societies, work together to make fracture prevention and healthy mobility a worldwide heath care priority. www.osteoporosis.foundation @iofbonehealth